Point-of-Care Coagulation Testing Market | Leading Segments, Trends, Drivers and Challenges
Market Forecast and Growth Projections 2021-2025
Global point-of-care coagulation testing market will post an incremental growth of $ 1.49 bn and progressing at a CAGR of over 8.41% during the forecast period. Our research report segments the market into major segments and the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.
Need more details on this market: Request for Our FREE Sample Report
Point-of-Care Coagulation Testing Market: Leading Segments and Growth Analysis
This research report will provide insights into the current market share of each segment along with growth projections for the next five years.
- The Point-of-Care Coagulation Testing Market is segmented by End-user (hospitals and clinics and homecare) and Geography (North America, Europe, Asia, and ROW).
- 46% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Point-of-Care Coagulation Testing Market size.
Point-of-Care Coagulation Testing Market: Top Trends, Drivers, Challenges to drive Market Recovery
Our report helps market players to discover the various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will provide clients with all the information they would require for designing a growth strategy for their business.
- A key market driver for the Point-of-Care Coagulation Testing Market will be growing geriatric population.
- Another factor that will boost the market will be the Growing technological innovations in point-of-care testing.
- Lack of trained professionals is a challenge that needs to be overcome to persist on the path to growth and recovery from the impact of the pandemic.
Point-of-Care Coagulation Testing Market: Vendor Analysis
- The market is fragmented.
- The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
- Abbott Laboratories, Danaher Corp., DIAGNOSTICA STAGO SAS, F. Hoffmann-La Roche Ltd., Helena Laboratories Corp., iLine Microsystems SL, Medtronic Plc, Micropoint Bioscience Inc., Siemens AG, and Sysmex Corp. are some of the major market participants.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
The report provides insights into the following FAQs:
- What is the market CAGR?
The market is accelerate at a CAGR of over 8.41%.
- What is the incremental growth of the market?
The market is expected to grow by $ 1.49 bn through 2021-2025.
- What is a key factor driving this market?
Growing geriatric population will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
46% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are Abbott Laboratories, Danaher Corp., DIAGNOSTICA STAGO SAS, F. Hoffmann-La Roche Ltd., Helena Laboratories Corp., iLine Microsystems SL, Medtronic Plc, Micropoint Bioscience Inc., Siemens AG, and Sysmex Corp.
- What are the market segments covered in this report?
The market is segmented by End-user (hospitals and clinics and homecare) and Geography (North America, Europe, Asia, and ROW)
